Recruiting
Asthma
RecruitingInvestigational
A Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma
Investigational
Countries:
The Netherlands
The Netherlands- Participants:18–64 years
- Substances:LY3537031
Find therapies in clinical trials near you
- recruiting
- 3 962
- countries
- 28
- conditions
- 2 101
3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today
53 trials match your criteria
Recruiting
Arteriosclerosis
RecruitingInvestigational
Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
Investigational
- Disease:Arteriosclerosis
- Substances:Maridebart Cafraglutide
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Maridebart Cafraglutide
Recruiting
Registered drug
Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
Registered drug
- Disease:Heart failure with preserved ejection fraction
- Substances:Azd5004Dapagliflozin
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Azd5004
Recruiting
B-cell small lymphocytic lymphoma
RecruitingRegistered drugNo placebo
A study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia
Registered drugNo placebo
- Disease:B-cell small lymphocytic lymphoma
- Substances:AcalabrutinibVenetoclax+2
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Acalabrutinib
Recruiting
Triple negative breast cancer
RecruitingRegistered drugNo placebo
Study of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment
Registered drugNo placebo
- Disease:Triple negative breast cancer
- Substances:CapecitabineGimeracil+4
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Capecitabine
Recruiting
Chronic kidney disease+1
RecruitingInvestigational
A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
Investigational
- Disease:Chronic kidney diseaseArteriosclerosis
- Substances:–
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
Recruiting
B-cell small lymphocytic lymphoma refractory+1
RecruitingRegistered drugNo placebo
Study of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
Registered drugNo placebo
- Disease:B-cell small lymphocytic lymphoma refractoryB-cell small lymphocytic lymphoma recurrent
- Substances:ObinutuzumabRituximab+2
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Obinutuzumab
Recruiting
Polycystic ovarian syndrome
RecruitingRegistered drugNo placebo
Study on Letrozole and Gonadotropins for Women with Polycystic Ovary Syndrome (PCOS) to Improve Live Birth Rates
Registered drugNo placebo
- Disease:Polycystic ovarian syndrome
- Substances:Follitropin AlfaLetrozole+1
Countries:The Netherlands
The Netherlands- Participants:18–64 years
- Substances:Follitropin Alfa
Recruiting
Rectal cancer
RecruitingRegistered drugNo placebo
Study Comparing Surgery and Chemoradiotherapy with Capecitabine for Early Rectal Cancer Patients
Registered drugNo placebo
- Disease:Rectal cancer
- Substances:Capecitabine
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Capecitabine
Recruiting
Ischaemic stroke
RecruitingRegistered drugNo placebo
Study on Statins for Frail Older Patients with Recent Ischemic Stroke or TIA: Fluvastatin, Simvastatin, Pravastatin Sodium, Atorvastatin, and Rosuvastatin Combination
Registered drugNo placebo
- Disease:Ischaemic stroke
- Substances:AtorvastatinFluvastatin+3
Countries:The Netherlands
The Netherlands- Participants:65+ years
- Substances:Atorvastatin
Recruiting
Hypothyroidism
RecruitingRegistered drug
Study on Levothyroxine and Liothyronine for Patients with Autoimmune Hypothyroidism and Persistent Tiredness
Registered drug
- Disease:Hypothyroidism
- Substances:–
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
Recruiting
Uterine leiomyoma
RecruitingRegistered drugNo placebo
Study Comparing Ulipristal Acetate and Surgery for Women with Symptomatic Uterine Fibroids
Registered drugNo placebo
- Disease:Uterine leiomyoma
- Substances:Ulipristal Acetate
Countries:The Netherlands
The Netherlands- Participants:18–64 years
- Substances:Ulipristal Acetate